Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus

European Journal of Preventive Cardiology
Yu KataokaStephen J Nicholls

Abstract

Diabetic patients with coronary artery disease (CAD) demonstrate accelerated progression of coronary atherosclerosis. The impact of multiple risk factor intervention on disease progression has not been investigated. We investigated 448 diabetic patients with angiographic CAD who underwent serial intravascular ultrasound imaging to monitor the change in atheroma burden in seven clinical trials. Disease progression was compared in patients stratified according to whether they achieved increasing numbers of treatment goals of individual risk factors (HbA1c <7.0%, LDL cholesterol <2.5 mmol/l, triglyceride <1.7 mmol/l, systolic blood pressure <130 mmHg, high sensitivity C-reactive protein <2.0 mg/l). A high rate of established medical therapies was used in all patients (89% statins, 94% aspirin, 76% β-blockers, 66% ACE inhibitors, 66% metformin, 62% thiazolidinediones, 17% insulin). No differences were observed with regard to percentage atheroma volume (PAV) and total atheroma volume (TAV) at baseline. On serial evaluation, slowing of progression of PAV (p = 0.01) and TAV (p < 0.001) was observed with increasing numbers of risk factors achieving treatment goals. On multivariate analysis adjusting for baseline risk factors, increasin...Continue Reading

References

Apr 17, 2002·Annals of Internal Medicine·Jinan B SaaddineK M Venkat Narayan
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN REVERSAL Investigators
May 27, 2004·Diabetes Care·Ronald M Krauss
Aug 31, 2004·Diabetes Care·Guenther Boden, Markku Laakso
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN CAMELOT Investigators
Jun 1, 2005·Archives of Medical Research·Henry N GinsbergAntonio Hernandez-Ono
Jan 31, 2006·Diabetes Care·Barbara V HowardRichard B Devereux
Mar 15, 2006·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN ASTEROID Investigators
Mar 24, 2006·The New England Journal of Medicine·Steven E NissenUNKNOWN ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators
Mar 28, 2007·The New England Journal of Medicine·Steven E NissenUNKNOWN ILLUSTRATE Investigators
Sep 14, 2007·The American Journal of Medicine·Patrick J Boyle
Apr 2, 2008·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN PERISCOPE Investigators
Apr 5, 2008·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN STRADIVARIUS Investigators
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jul 19, 2008·Journal of the American College of Cardiology·Stephen J NichollsSteven E Nissen
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Apr 10, 2009·JACC. Cardiovascular Imaging·Young Joon HongJung Chaee Kang
Nov 27, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Christoph H SaelyHeinz Drexel
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
Mar 20, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anne VlekUNKNOWN SMART study group
Jun 12, 2010·Journal of the American College of Cardiology·Ozgur BayturanSteven E Nissen
Jul 8, 2010·JAMA : the Journal of the American Medical Association·Rhonda M Cooper-DeHoffCarl J Pepine
Sep 1, 2011·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ingrid HopperHenry Krum

❮ Previous
Next ❯

Citations

Jun 14, 2013·Clinical Interventions in Aging·Xavier Castellon, Vera Bogdanova
Jan 15, 2014·Matrix Biology : Journal of the International Society for Matrix Biology·Natasha M RogersJeffrey S Isenberg
Feb 11, 2015·Oncology Letters·Haiyan ChenGuangzhu Lin
Jan 21, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Yu KataokaStephen J Nicholls
Jul 20, 2014·Circulation. Cardiovascular Imaging·Kanako K KumamaruFrank J Rybicki
Aug 16, 2017·Journal of Diabetes Research·Sâmia Cruz Tfaile CorbiRaquel Mantuaneli Scarel-Caminaga

❮ Previous
Next ❯

Software Mentioned

ILLUSTRATE
SAS

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.